Study limitations included the lack of generalizability to patients in later stages of ALS, risk of including ALS mimics, shorter treatment duration of 16 weeks vs the typical 24 weeks in other clinical trials, small sample size, and lack of evaluation of specific disease-related biomarkers
Our trained clinical practitioners can help you determine which B12 therapy best supports your wellness goals
Proper patient selection, thorough informed consent, and rigorous cardiovascular and metabolic monitoring are essential when integrating emerging peptides into practice protocols
Our pharmacist will review the information you provide and advise whether the pharmacy service is suitable, whether a blood test may be helpful, or whether you should speak to your GP or another healthcare professional
Please note that this isn't meant to be used for patient therapy/therapeutic anticoagulation doses
allowing for me to healthily continue my new life and new job while waiting for a visit